Key result
Vagus nerve stimulation serves as an effective adjunctive treatment for intractable epilepsy, offering progressive seizure reduction and improved quality of life with mild, transient side effects.
Why the study?
Does vagus nerve stimulation improve seizure reduction and quality of life in patients with intractable epilepsy?
Does vagus nerve stimulation improve seizure reduction and quality of life in patients with intractable epilepsy?
Vagus nerve stimulation is a safe and effective adjunctive treatment for intractable epilepsy, offering long-term seizure reduction and improved quality of life.
Answers are grounded in this paper and cite their sources.
May support VNS consideration for surgery-ineligible intractable epilepsy; leaves open prospective validation of progressive seizure reduction.
approved as an adjunctive therapy for patients with intractable epilepsy in 1999 and has been covered by National Health Insurance in Korea since 2005. VNS is a particularly good option for patients with intractable epilepsy who are not eligible for epilepsy surgery or patients with a high drug load or nonadherence to anticonvulsants. The effect of seizure re-duction by VNS tends to gradually increase in proportion to the duration of treatment. Common side effects are usually mild and transient, including voice change, paresthesia in the neck or throat, and cough. The role of VNS is expected to expand in the future as a substantial proportion of patients show better quality of life with improvements in cognition, language, and behavior, as well as seizure reduction.
No takes yet. Share an insight, caveat, or question.
Sang Ook Nam (2021) conducted a review in Intractable epilepsy. Vagus nerve stimulation (VNS) was evaluated. Vagus nerve stimulation serves as an effective adjunctive treatment for intractable epilepsy, offering progressive seizure reduction and improved quality of life with mild, transient side effects.
Synapse has enriched 10 related papers. Consider them for comparative context: